Drano,DoubleJ123 or any long term member here who I consider "reliable",correct me if
I'm misstaken .

If I understand correctly,B-OM getting BTD would also include getting priority review.
I am guessing that the BP suitor is waiting for that determination as it greatly
enhances the value and of course also greatly reduces the costs of moving forward with
B-OM.

If it applies strictly to B-OM,that's great but if they get a priority review voucher
that can be sold for 100's of millions,well,looks like the rest of the current drugs
(B ABSSSI,P,K just got their P3's pretty well paid for also , right?

Either way what's that worth to a BP???

Just thinking out loud.

Kelt